These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35417613)
21. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes. Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695 [TBL] [Abstract][Full Text] [Related]
22. Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Taniguchi A; Fukushima M; Nakai Y; Kuroe A; Yamano G; Yanagawa T; Ohgushi M; Ohya M; Yoshii S; Taki Y; Seino Y Metabolism; 2005 Mar; 54(3):376-80. PubMed ID: 15736116 [TBL] [Abstract][Full Text] [Related]
23. Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin. Becker A; van der Does FE; van Hinsbergh VW; Heine RJ; Bouter LM; Stehouwer CD Neth J Med; 2003 Apr; 61(4):129-36. PubMed ID: 12852722 [TBL] [Abstract][Full Text] [Related]
24. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management. Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598 [TBL] [Abstract][Full Text] [Related]
25. A longitudinal assessment of lipids in youth with type 1 diabetes. Reh CM; Mittelman SD; Wee CP; Shah AC; Kaufman FR; Wood JR Pediatr Diabetes; 2011 Jun; 12(4 Pt 2):365-71. PubMed ID: 21392191 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the Effects of Fasting Glucose, Hemoglobin A Su WY; Chen SC; Huang YT; Huang JC; Wu PY; Hsu WH; Lee MY Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752391 [TBL] [Abstract][Full Text] [Related]
27. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome. Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853 [TBL] [Abstract][Full Text] [Related]
28. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J; Hauptman J Diabetes Care; 1998 Aug; 21(8):1288-94. PubMed ID: 9702435 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770 [TBL] [Abstract][Full Text] [Related]
30. Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes. Blonde L; Pencek R; MacConell L Cardiovasc Diabetol; 2015 Feb; 14():12. PubMed ID: 25645567 [TBL] [Abstract][Full Text] [Related]
31. Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study. Li YY; Yang YM; Zhu S; Cheng H; Hernandez J; Huang W; Wang HHX; Li YT Front Endocrinol (Lausanne); 2023; 14():1112855. PubMed ID: 37124734 [TBL] [Abstract][Full Text] [Related]
32. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids. Taniguchi A; Nakai Y; Fukushima M; Teramura S; Hayashi R; Hama K; Marumoto K; Watanabe T; Yoshioka I; Sakaguchi K; Kishimoto H; Matsushita K; Okumura T; Tokuyama K; Nagasaka S; Sakai M Metabolism; 2002 May; 51(5):539-43. PubMed ID: 11979382 [TBL] [Abstract][Full Text] [Related]
33. Association of hemoglobin glycation index with cardiovascular risk factors in non-diabetic adults: A cross-sectional study. Rajendran S; Mishra S; Madhavanpillai M; G V Diabetes Metab Syndr; 2022 Sep; 16(9):102592. PubMed ID: 35998512 [TBL] [Abstract][Full Text] [Related]
34. Body Weight Reduction of 5% Improved Blood Pressure and Lipid Profiles in Obese Men and Blood Glucose in Obese Women: A Four-Year Follow-up Observational Study. Hasegawa Y; Nakagami T; Oya J; Takahashi K; Isago C; Kurita M; Tanaka Y; Ito A; Kasahara T; Uchigata Y Metab Syndr Relat Disord; 2019 Jun; 17(5):250-258. PubMed ID: 30839239 [No Abstract] [Full Text] [Related]
35. Alcohol consumption in the severely obese: relationship with the metabolic syndrome. Dixon JB; Dixon ME; O'Brien PE Obes Res; 2002 Apr; 10(4):245-52. PubMed ID: 11943832 [TBL] [Abstract][Full Text] [Related]
36. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Malik S; Lopez V; Chen R; Wu W; Wong ND Diabetes Res Clin Pract; 2007 Jul; 77(1):126-33. PubMed ID: 17118478 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Risk Factors in Patients with Poorly Controlled Diabetes Mellitus. Dizdarevic-Bostandzic A; Begovic E; Burekovic A; Velija-Asimi Z; Godinjak A; Karlovic V Med Arch; 2018 Feb; 72(1):13-16. PubMed ID: 29416211 [TBL] [Abstract][Full Text] [Related]
38. Effects of weight variability on cardiovascular risk factors; a study of nonsmoking Japanese male office workers. Nakanishi N; Nakamura K; Suzuki K; Tatara K Int J Obes Relat Metab Disord; 2000 Sep; 24(9):1226-30. PubMed ID: 11033995 [TBL] [Abstract][Full Text] [Related]